Clinical trials

  • DATOPOTAMAB DERUXTECAN for Triple-negative breast cancer | Residual invasive breast cancer
  • HER3-DXd for Inoperable advanced breast cancer|HER2-positive breast cancer|HER2-low breast cancer
  • NAVENIBART for Hereditary angioedema | Hereditary angioedema type 1 | Hereditary angioedema type 2
  • CEREBROLYSIN CONCENTRATE for CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)
  • BI 765179 for Advanced head and neck cancer
  • efanesoctocog alfa for Haemophilia A
  • Mycophenolate mofetil for Kidney transplantation
  • XmAb24306 for Locally advanced or metastatic solid tumors
  • CROVALIMAB for Paroxysmal nocturnal hemoglobinuria (PNH)
  • Sodium lactate for Post-anoxic brain injury | Post-cardiac arrest syndrome | Coma | Cardiac arrest
  • fisetin for Healthy volunteers | Multimorbidity
  • OSIMERTINIB for Non-small cell lung cancer (stage IB-IIIA) with EGFR sensitising mutations (Ex19del, L858R)